One-stop Preclinical Services for Cancer Research

At Alfa Cytology, we offer a comprehensive suite of preclinical services tailored to advance cancer research and drug development. Our one-stop preclinical platform provides end-to-end solutions, from disease modeling and diagnostic development to therapeutic evaluation - all under one roof.

Key Advantages:

Diverse Cancer Models - We maintain a wide range of cancer cell lines, patient-derived xenografts, and genetically engineered mouse models to accurately reflect the heterogeneity of various cancer types.

Efficient Therapeutic Screening - Our high-throughput screening capabilities and in vivo testing platforms accelerate the evaluation of novel drug candidates and combination therapies.

Integrated Data Analysis - Our experienced team provides comprehensive data analysis and reporting to guide your research and development decisions.

Regulatory Compliance - We adhere to the highest standards of quality, safety, and ethical practices to ensure your preclinical studies meet regulatory requirements.

With our extensive expertise and integrated services, we are your trusted partner in accelerating cancer research and driving breakthroughs in diagnostics and therapeutics. Please contact us for more information.

Diagnostic Development Platform

Cancer Biomarker Discovery
Imaging Services
Multi-omics Services

Cancer Modeling Platform

Advanced Cellular Models
3D Tumor Modeling
PDX Model
CDX Model
Syngeneic Tumor Model

Therapeutic Development Platform

Small Molecule Drug
Cell Therapy
Gene Therapy

Antibody
Therapeutic Peptide
Cancer Vaccine